Siton, Ralp Vincent .

HRN: 26-90-97  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2025
AMPICILLIN 500MG (VIAL)
04/05/2025
04/12/2025
INTRAVENOUS
50 Mg
Every 12 Hours
Sepsis Neonatorum
Waiting Final Action 
04/05/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/05/2025
04/12/2025
INTRAVENOUS
30 Mg
Every 36 Hours
Sepsis Neonatorum
Waiting Final Action 
04/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/06/2025
04/13/2025
IV
25mg LD Then 13mg Maintenance
13mg Q24 Hours
Sepsis Neonatorum
Waiting Final Action 
04/06/2025
CEFOTAXIME 500MG (VIAL)
04/06/2025
04/13/2025
IV
85mg
Q12 Hours
Sepsis Neonatorum
Waiting Final Action 
04/09/2025
CEFTAZIDIME 1GM (VIAL)
04/09/2025
04/15/2025
IV DRIP
85mg
Q8
Sepsis Neonatorum
Waiting Final Action 
04/10/2025
AMPICILLIN 500MG (VIAL)
04/10/2025
04/16/2025
IVTT
85mg
Q12h
Sepsis Neonatorum
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: